KC
Kalpana Chauhan
About Kalpana Chauhan
Data last updated:
Kalpana Chauhan is a Director at Giowill Pharma Private Limited (since 2019) and Director at Vellmine Lifescience Private Limited (since 2024). The companies operate in Pharma. The largest current company by reported revenue is Giowill Pharma Private Limited at ₹1.19 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Giowill Pharma Private Limited U24304UR2019PTC010397 | Director | 11 Nov 2019 | 2019 | ₹1.19 Cr (FY 2025) | Active |
| Vellmine Lifescience Private Limited U46497UT2024PTC018196 | Director | 14 Nov 2024 | 2024 | Active |
Board colleagues of Kalpana Chauhan
| Name | DIN | Company | Designation |
|---|---|---|---|
| Bipin Kumar | 07678511 | Giowill Pharma Private Limited , Vellmine Lifescience Private Limited | Director |
| Kirti | 11522395 | Giowill Pharma Private Limited | Director |
| Rashmi Tiwari | 11522376 | Giowill Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kalpana Chauhan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kalpana Chauhan
Kalpana Chauhan currently holds 2 directorships: Giowill Pharma Private Limited (Director, since 11 Nov 2019, revenue ₹1.19 Cr (FY 2025)); Vellmine Lifescience Private Limited (Director, since 14 Nov 2024).
Kalpana Chauhan was first appointed on 11 Nov 2019 as Director at Giowill Pharma Private Limited. The most recent appointment on record is 14 Nov 2024 at Vellmine Lifescience Private Limited.
The current boards of Kalpana Chauhan's companies include Bipin Kumar (Giowill Pharma Private Limited), Kirti (Giowill Pharma Private Limited), Rashmi Tiwari (Giowill Pharma Private Limited).